Why these 4 ASX shares have dropped lower today

Although the S&P/ASX 200 (Index: ^AXJO) (ASX: XJO) has given back some of its morning gains, in afternoon trade the benchmark index is still 0.1% higher at 6,076 points.

Four shares that haven’t been able to follow the market higher today are listed below. Here’s why they have dropped lower:

The MGC Pharmaceuticals Ltd (ASX: MXC) share price has fallen 3% to 9.1 cents despite the rally in pot stocks. Investors appear to believe that the Federal Government’s decision to allow medicinal cannabis exports could be a negative for the Europe-based cannabis company.

The Qantas Airways Limited (ASX: QAN) share price has dropped almost 2% to $4.91. Today’s decline is likely to be related to a rise in the oil price overnight. Oil prices hit two-year highs overnight, possibly leading to concerns over an increase in the airline’s fuels costs.

The Sigma Healthcare Ltd (ASX: SIG) share price is down 3% to 99 cents despite there being no news out of the company. Investors have been heading to the exits in their droves over the last 12 months due to its underwhelming performance and concerns over its supply agreement with Chemist Warehouse.

The St Barbara Ltd (ASX: SBM) share price has tumbled 4% to $3.76. The majority of Australia’s gold miners have fallen into the red after the gold price gave back a portion of its recent gains overnight. This happened after minutes released from the recent FOMC meeting revealed that most members backed gradual rate rises in the United States.

If your portfolio needs a big lift in 2018 then I would suggest you consider this huge opportunity that has been described as being worth 10 Microsofts.

Bill Gates Says This Could Be Worth "10 Microsofts"

If You Missed Investing In Microsoft in 1996 - Read This

I can't believe so many investors haven't heard about something Microsoft founder Bill Gates told a group of college students in 2004.

This could be your chance to get in on the ground floor!

Click here to discover more!

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

Two New Stock Picks Every Month!

Not to alarm you, but you’re about to miss a very important event! Chief Investment Advisor Scott Phillips and his team at Motley Fool Share Advisor are about to reveal their latest official stock recommendation. The premium “buy alert” will be unveiled to members and you can be among the first to act on the tip.

Don’t let this opportunity pass you by – this is your chance to get in early!

Simply enter your email now to find out how you can get instant access.

By clicking this button, you agree to our Terms of Service and Privacy Policy. We will use your email address only to keep you informed about updates to our website and about other products and services we think might interest you. You can unsubscribe from Take Stock at anytime. Please refer to our Financial Services Guide (FSG) for more information.